A pre-treatment pill may supercharge cancer-fighting immune cells
Disease control
Not yet recruiting
This early-phase trial tests whether giving the drug iberdomide before collecting a patient's T cells can improve the fitness of those cells for CAR-T therapy. The study enrolls adults with relapsed or refractory multiple myeloma who are already scheduled for standard CAR-T treat…
Phase: EARLY_PHASE1 • Sponsor: Shambavi Richard • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC